By analyzing single‐cell transcriptomic data from 5 neuroblastoma patients with MYCN amplification and 7 patients without MYCN amplification (GSE21840), and applying machine learning approaches, we identified five candidate pathogenic genes potentially associated with MYCN amplification. Here, MYCN is linked to neuroblastoma.